Prelude Capital Management’s Johnson & Johnson JNJ Stock Holding History

Prelude Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,300	Closed	-$564K	–	2109
2020 Q1	$564K	Sell	4,300 -8,200	-66%	-$1.16M	0.04%	304
2019 Q4	$1.82M	Sell	12,500 -12,500	-50%	-$1.7M	0.07%	238
2019 Q3	$3.23M	Buy	+25,000	New	+$3.29M	0.15%	94
2019 Q2	–	Sell	-22,500	Closed	-$3.15M	–	1900
2019 Q1	$3.15M	Buy	+22,500	New	+$3.01M	0.18%	104

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Prelude Capital Management's JNJ Position: Q2 2026 in Review

Prelude Capital Management opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 1,370 shares worth $348K. The stake represents 0.03% of the portfolio and ranks #689 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in JNJ as recently as Q4 2025.

Prelude Capital Management first reported a position in JNJ in Q2 2013 and has held it in 34 quarters since. The position peaked at $3.58M in Q3 2024. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Prelude Capital Management held 1,370 shares of Johnson & Johnson worth $348K as of Q2 2026.
Johnson & Johnson was a new Prelude Capital Management position in Q2 2026.
Johnson & Johnson made up 0.03% of Prelude Capital Management's portfolio in Q2 2026, its #689 holding.
Prelude Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 34 quarters since.
Prelude Capital Management's Johnson & Johnson position peaked at $3.58M in Q3 2024.
4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.